Accustem Sciences
Why Robinhood?
You can watch ACUT and buy or sell other stocks, ETFs, and their options commission-free!About ACUT
AccuStem Sciences, Inc. is a clinical stage diagnostics company, which engages in medical practice activities. It also focuses on commercialization of a proprietary genomic test, StemPrintER, for patients with early-stage breast cancer.
ACUT Key Statistics
Stock Snapshot
As of today, Accustem Sciences(ACUT) shares are valued at $0.19. The company's market cap stands at 3.05M, with a P/E ratio of -1.69.
On 2026-07-25, Accustem Sciences(ACUT) stock moved within a range of $0.18 to $0.22. With shares now at $0.19, the stock is trading +8.6% above its intraday low and -13.6% below the session's peak.
Trading activity shows a volume of 10, compared to an average daily volume of 3.17K.
The stock's 52-week range extends from a low of $0.16 to a high of $2.33.
The stock's 52-week range extends from a low of $0.16 to a high of $2.33.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.